Effect of intraoperative intravenous infusion of Lidocaine on postoperative recovery quality of patients with esophageal cancer

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041715

Enrollment

Unknown

Registered

2021-01-02

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

experimental group:Intraoperative intravenous infusion of lidocaine

control group:10/5000 Intraoperative intravenous saline infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with esophageal cancer surgery, any age, ASA class I ~ III.

Exclusion criteria

Exclusion criteria: Persons with known comorbidities of neurologic function or mental disorders, and persons with known allergy to local anesthetics.

Design outcomes

Primary

Measure	Time frame
QoR-15;	—

Countries

China

Contacts

Public ContactDai Shuangbo

Fujian Provincial Hospital

dsbosl@126.com+86 13358215103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026